DRAMATIC RESPONSE OF CACHEXIA TO ANTI-TNF THERAPY IN JUVENILE IDIOPATHIC ARTHRITIS

被引：0
|
作者：
Harrison, K. [1 ,2 ]
McDonagh, J. E. [1 ,2 ]
机构：
[1] Birmingham Childrens Hosp, Birmingham, W Midlands, England
[2] Univ Birmingham, Birmingham, W Midlands, England
来源：
RHEUMATOLOGY | 2014年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
44
引用
收藏
页码：16 / 16
页数：1
相关论文
共 50 条
  • [41] High levels of DEK autoantibodies may predict early flare following cessation of anti-TNF therapy in juvenile idiopathic arthritis
    Nirit Mor-Vaknin
    Miguel Rivas
    Maureen Legendre
    Y Yuanfang
    Anne Johnson
    Bin Huang
    Yuki Kimura
    Lili Zhao
    Steve Spalding
    Paula Morris
    Beth Gottlieb
    Karen Onel
    Judyann Olson
    Barbara Edelheit
    Michael Shishov
    Larry Jung
    Elaine Cassidy
    Sampath Prahalad
    Murray Passo
    Timothy Beukelman
    Jay Mehta
    Kara Schmidt
    Ed Giannini
    Daniel Lovell
    David Markovitz
    Pediatric Rheumatology, 12 (Suppl 1)
  • [42] MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis
    Janneke Anink
    Lisette W. A. Van Suijlekom-Smit
    Marieke H. Otten
    Femke H. M. Prince
    Marion A. J. van Rossum
    Koert M. Dolman
    Esther P. A. H. Hoppenreijs
    Rebecca ten Cate
    Simona Ursu
    Lucy R. Wedderburn
    Gerd Horneff
    Michael Frosch
    Thomas Vogl
    Faekah Gohar
    Dirk Foell
    Johannes Roth
    Dirk Holzinger
    Arthritis Research & Therapy, 17
  • [43] Humoral Immune Response after a Booster Dose with Tdap in Children and Adolescents with Juvenile Idiopathic Arthritis on Anti-TNF and in Healthy Controls
    Nicacio, Aline
    Peracchi, Octavio
    Yamada, Juliana
    Spina, Fernanda
    Alvarenga, Brunna
    Pinto, Maria Isabel
    Terreri, Maria Teresa
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [44] MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis
    Anink, Janneke
    Van Suijlekom-Smit, Lisette W. A.
    Otten, Marieke H.
    Prince, Femke H. M.
    van Rossum, Marion A. J.
    Dolman, Koert M.
    Hoppenreijs, Esther P. A. H.
    ten Cate, Rebecca
    Ursu, Simona
    Wedderburn, Lucy R.
    Horneff, Gerd
    Frosch, Michael
    Vogl, Thomas
    Gohar, Faekah
    Foell, Dirk
    Roth, Johannes
    Holzinger, Dirk
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [45] Efficacy and safety of switching etanercept to an anti-TNF monoclonal antibody in patients with juvenile idiopathic arthritis.
    Russo, Ricardo A.
    Katsicas, Maria M.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S681 - S682
  • [46] Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFα agents
    Saurenmann, R. K.
    Levin, A. V.
    Feldman, B. M.
    Laxer, R. M.
    Schneider, R.
    Silverman, F. D.
    JOURNAL OF PEDIATRICS, 2006, 149 (06): : 833 - 836
  • [47] Predictors of the Need for Anti-TNF Alpha Drugs in Patients With Juvenile Idiopathic Arthritis-Associated Uveitis
    Yildirim, Deniz Gezgin
    Belder, Nuran
    Ozdemir, Huseyin Baran
    Bakkaloglu, Sevcan A.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2025, 28 (01)
  • [48] Anti-TNF therapy does not suppress TST response in rheumatoid arthritis patients
    Medina, F
    Ramirez, R
    Hernandez, R
    Portela, M
    Barile, L
    Fuentes, J
    Fraga, A
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 409 - 409
  • [49] Genetics: PTPRC mutation associated with response to anti-TNF therapy in rheumatoid arthritis
    Higgs R.
    Nature Reviews Rheumatology, 2010, 6 (6) : 311 - 311
  • [50] Does smoking predict poor response to anti-TNF therapy for rheumatoid arthritis?
    Moorthy, A.
    Fisher, J.
    Duncan, A.
    Taylor, J.
    RHEUMATOLOGY, 2007, 46 : I31 - I31
12345